Click Here to return To Results

 

Intravenous Immunoglobulin in Secondary Progressive Multiple Sclerosis: Randomised Placebo-Controlled Trial Lancet 364:1149-1156, Hommes,O.R.,et al, 2004 See this aricle in Pubmed Article Abstract Treatment with IVIG in this study did not show any clinical benefit and therefore cannot be recommended for patients with secondary progressive multiple sclerosis.

Related Tags

(click to filter results - removes previous filter) gammaglobulin therapy,intravenous multiple sclerosis multiple sclerosis,secondary progressive multiple sclerosis,treatment of

Click Here to return To Results